This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $16,582.91 contract is for the provision of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers such as glioblastoma and mesothelioma. The contract is not set aside and is awarded...
This is a firm-fixed-price purchase order awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $16,582.91 and a performance period ending on October 9, 2024. The award is for Optune Plus Transducer, part of Novocure's proprietary Optune system that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and other...
This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the delivery of Optune Plus Transducers, which are part of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract is not set aside and is part of a larger $28.85...
This is a $49,748.73 firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of tumor treating fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's efforts to expand veteran access to...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide Optune Plus Transducers. The order has a potential value of $49,748.73 and a completion date of May 31, 2024. This order is part of a larger 5-year Federal Supply Schedule (FSS) contract with the VA VHA valued at up to $28.85 million, which allows the VA to efficiently procure Novocure's Optune tumor...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus Transducers, a cancer therapy product utilizing Tumor Treating Fields (TTFields) technology. The contract does not have a set-aside designation and is part of Novocure's 5-year, $28.85 million Federal...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) therapy devices, transducer arrays, and related equipment rentals and support services for the treatment of solid tumor cancers, including glioblastoma, for veterans at VA medical centers and clinics. The contract has a potential value of $103,914.55 and a...
This is a $49,748.73 firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services for the treatment of glioblastoma and mesothelioma at VA medical facilities. The...